Recent BioUtah News & Events

The groundbreaking HerediGene: Children’s Study – the world’s largest DNA mapping effort ever to be undertaken in kids – is now offering additional collection methods for children to participate at Intermountain Primary Children’s Hospital, including a new simple cheek swab.

Epitel’s second publication has been accepted for publication in a special edition of Frontiers Neurology.

Intermountain Healthcare is launching Tellica Imaging, a subsidiary company which will open and operate stand-alone outpatient imaging centers at easy-to-access locations.

Foldax®, Inc. announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve.

On September 27, 2021, IONIQ Sciences announced that Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee.

Co-Diagnostics, Inc. announced that following its recent transformative growth, the Company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals.

Each year, BioUtah publishes a special Utah life sciences magazine, released with the September issue of Utah Business Magazine, Our 2021 issue is our biggest yet with a feature story on the “Rise of BioHive.” We’ve also given the magazine a new name – Biosphere – to match our efforts to boldly brand and build […]

Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births, neonatal intensive care admissions, overall hospital length of stay and a net $54 million reduction in total costs in the analyzed population Salt Lake City – September 14, 2021 – […]

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Influenza A/Influenza B/COVID-19 “ABC” Test has been approved for sale in Mexico by the Mexican Department of Epidemiology (“InDRE”) after InDRE successfully concluded an independent evaluation of the test’s sensitivity […]

Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA) will add a new doc to the team. Dr. Michael R. Foley has been appointed to the position of Chief Medical Officer starting in January 2022. Salt Lake City-based Sera Prognostics focuses on neonatal health as well as maternal health using biomarker information. Using PreTRM® test reports, […]

SALT LAKE CITY (September 21, 2021)—Andrew Fletcher, MD, medical director of Consultative Services at ARUP Laboratories, and ARUP’s Consultative Services team, led by Sandy Richman, are among six healthcare leaders and systems honored with 2021 Choosing Wisely Champion Awards from the American Society for Clinical Pathology (ASCP). Launched in 2016, the Choosing Wisely Champions Program […]

This week Xenter, Backcountry, and Sera Prognostics announced changes to their executive teams. Here’s the deets: Xenter Salt Lake City, Utah-based Xenter, Inc. (XenterMD.com) has announced a new President of Xenter Medical Technologies (formerly Xenter Hospital Technologies) business unit. Mark Turco, MD, is highly qualified, coming from Sirtex Medical where he served as Executive Vice […]

Intermountain Healthcare and SCL Health, two leading nonprofit healthcare organizations, have signed a Letter of Intent to merge and create a model health system that provides high-quality, accessible, and affordable healthcare to more patients and communities in Utah, Idaho, Nevada, Colorado, Montana, and Kansas. Upon completion of the merger, the combined system will employ more […]

CMS Proposes MCIT Repeal On September 13, CMS issued a proposed rule to repeal the Medicare Coverage of Innovative Technology (MCIT) pathway initally finalized in a January 14, 2021 rule.  The MCIT pathway would have provided four years of immediate Medicare coverage for FDA-designated breakthrough medical devices and diagnostics that have been market authorized – […]

Congressional committees this week got down to business writing the details of the Biden Administration’s $3.5 trillion “Build Back Better” reconciliation bill. Of particular interest to the life sciences industry was consideration of drug price control provisions in the House Energy and Commerce and Ways and Means Committees. In its version of “Build Back Better,” […]

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD). KidneyIntelX enables a shift in focus from care […]

Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.” […]

The Saragene test kits approved by the CDSCO use the Company’s patented CoPrimer™ technology for the qualitative detection of these mosquito-borne viruses. According to the World Health Organization, the global incidence of dengue has grown dramatically in recent decades to become a leading cause of death in some Asian and Latin American countries, with 70% […]

AdvaMed, the leading global trade association for medical technology manufacturers, released the following statement from President and CEO Scott Whitaker on the Administration’s proposal to fully repeal the Medicare Coverage of Innovative Technologies (MCIT) rule.

On September 13th, Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion hosted by Scott Gottlieb, M.D., titled “How We Can Defeat the Next Pandemic” at the H.C. Wainwright & Co. 2021 Global Investor Conference, being held virtually on September 13-15, 2021.

Ultradent Products, Inc. is honored to be recognized a 2021 Fortune Magazine Best Workplace in Manufacturing and Production. The selection comes after a rigorous evaluation of company culture and extensive employee feedback. 

The Utah Governor’s Office of Economic Opportunity has renamed its Salesforce grant application and customer service portals as part of its rebranding. The office no longer goes by GOED, but by Go Utah, or the Economic Opportunity office.

The Utah Governor’s Office of Economic Opportunity (Go Utah) and the Economic Development Corporation of Utah (EDCUtah) are pleased to announce that Cytiva will expand its facility in Logan, Utah, adding up to 396 new high-paying Utah jobs in the next 10 years. Capital expenditures associated with the project are $231 million.

Newly released data from the University of Utah’s Kem C. Gardner Policy Institute shows that Utah’s mature life sciences industry – our BioHive – continues to experience strong growth relative to state and national trends, even during the pandemic.